Approval · Notice of Compliance 22922 · 2019
EMLA PATCH: Notice of Compliance 22922
Issued November 19, 2019
A Notice of Compliance is Health Canada’s approval of a drug submission: a new drug, a new use or form, or a change to an approved one. The product itself is in the Drug Product Database, with its current status.
- Notice number
- 22922
- Date
- November 19, 2019
- Company
- Aspen Pharmacare Canada Inc.Oakville, Ontario, Canada
- Product type
- Nonprescription Pharmaceutical
- Submission
- Supplement to a New Drug Submission (SNDS), supplement
- Submission class
- Other
- Reason
- To obtain regulatory approval for a new supplier
Products in this notice
| Brand | DIN | Status today |
|---|---|---|
| EMLA PATCH | Not yet assigned | — |
Medicinal ingredients
- LIDOCAINE 2.5 PER
- PRILOCAINE 2.5 PER